2014
DOI: 10.1007/s00251-014-0802-5
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of binding specificities of bovine leucocyte class I molecules: impacts for rational epitope discovery

Abstract: The binding of peptides to classical major histocompatibility complex (MHC) class I proteins is the single most selective step in antigen presentation. However, the peptide-binding specificity of cattle MHC (bovine leucocyte antigen, BoLA) class I (BoLA-I) molecules remains poorly characterized. Here, we demonstrate how a combination of high-throughput assays using positional scanning combinatorial peptide libraries, peptide dissociation, and peptide-binding affinity binding measurements can be combined with b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
59
0

Year Published

2015
2015
2024
2024

Publication Types

Select...
7
2

Relationship

7
2

Authors

Journals

citations
Cited by 22 publications
(63 citation statements)
references
References 39 publications
4
59
0
Order By: Relevance
“…2A). 41,54,55 Data generated by this assay were used for training of prediction algorithms. 56,57 It has been reported that pMHC complexes stability, as measured by a scintillation proximity assay, better correlates with immunogenicity than binding affinity.…”
Section: Mhc Class I Peptide Binding Validationmentioning
confidence: 99%
“…2A). 41,54,55 Data generated by this assay were used for training of prediction algorithms. 56,57 It has been reported that pMHC complexes stability, as measured by a scintillation proximity assay, better correlates with immunogenicity than binding affinity.…”
Section: Mhc Class I Peptide Binding Validationmentioning
confidence: 99%
“…Earlier studies have demonstrated the ability of this method to accurately predict peptides that bind to MHC I, including BoLA-1 molecules [29][30][31], and the method has proved useful as a guide to confirm whether identified epitope sequences are indeed minimal epitopes [32]. Therefore, these analyses set out to: (i) quantify the degree to which in silico predictions are capable of identifying the validated epitopes; and (ii) identify possible alternative peptide variants (extensions or fragments) of the validated epitopes predicted to have improved binding affinity to the BoLA-I restriction element.…”
Section: In Silico Validationmentioning
confidence: 99%
“…Recombinnt BoLA-1*00901 and human beta-2 microglobulins (β2m) were produced as previously described (61). In brief, biotinylated BoLA-1*00901 was generated in Escherichia coli, harvested as inclusion bodies, extracted into Tris-buffered 8 M urea and purified using ion exchange, hydrophobic, and gel filtration chromatographies.…”
Section: Model Performance Evaluationmentioning
confidence: 99%
“…Nonameric peptide binding motifs were determined for BoLA-1*00901, using PSCPL as previously described (34,61,63). Recombinant, biotinylated BoLA heavy chain molecules in 8 M urea were diluted at least 100-fold into PBS buffer containing 125I-labeled human β2m and peptide to initiate pMHC-I complex formation.…”
Section: Model Performance Evaluationmentioning
confidence: 99%